Basel Medical Group Ltd Ordinary Shares
BMGLNASDAQHealthcare● Active
$0.59
+$0.05(+9.20%)
Market Cap$11170007
P/E Ratio—
52W High$5.07
52W Low$0.383
Basel Medical Group Ltd Ordinary Shares（BMGL）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · BMGL · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-06 | 2024-06 | 2023-06 | 2022-06 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $11.32M | $10.05M | $9.70M | $10.66M |
| Cost of Revenue | $2.53M | $2.25M | $2.34M | $2.18M |
| Gross Profit | $8.79M | $7.80M | $7.36M | $8.48M |
| Gross Margin %(computed) | 77.68% | 77.63% | 75.91% | 79.56% |
| Operating Expenses | ||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $6.54M | $3.64M | $3.27M | $4.04M |
| Total Operating Expenses | $10.98M | $5.61M | $5.36M | $6.01M |
| Operating Income | ($2.18M) | $2.20M | $2.00M | $2.47M |
| Operating Margin %(computed) | -19.28% | 21.84% | 20.64% | 23.21% |
| Interest Income | $0.08M | $0.00M | $0.30M | $0.25M |
| Interest Expense | $0.20M | $0.18M | $0.24M | $0.32M |
| Income Before Tax | ($12.51M) | $2.40M | $2.13M | $2.39M |
| Income Tax Expense | ($0.42M) | $0.33M | $0.35M | $0.41M |
| Net Income | ($12.09M) | $2.07M | $1.78M | $1.98M |
| Net Margin %(computed) | -106.78% | 20.62% | 18.38% | 18.56% |
| Per Share & EBITDA | ||||
| EPS (Basic) | $0.00 | $0.11 | $0.10 | $0.11 |
| Wtd Avg Shares | 0.00M | 18.75M | 18.75M | 18.75M |
| EBITDA | ($11.12M) | $3.11M | $2.93M | $3.28M |
| EBITDA Margin %(computed) | -98.24% | 30.94% | 30.17% | 30.80% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · SGD · M
深入了解Basel Medical Group Ltd Ordinary Shares
关于Basel Medical Group Ltd Ordinary Shares（BMGL）损益表
Basel Medical Group Ltd Ordinary Shares（BMGL）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，BMGL实现营收$0.01B，毛利润$0.01B（毛利率77.68%），净利润($0.01B)（净利率-106.78%）。
常见问题
BMGL · 4 问Basel Medical Group Ltd Ordinary Shares（BMGL）2025财年营收为$0.01B，同比up12.6%。
BMGL revenueBMGL salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09